Form SC 13G/A CYTOKINETICS INC Filed by: BIOTECHNOLOGY

0
3



News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.


 UNITED STATES

SECURITIES AND EXCHANGE
COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULES 13d-1(b), (c),
AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(b)

(Amendment No. 13)1

 

Cytokinetics, Incorporated

 (Name of Issuer)

Common Stock, $0.001 par value per share

 (Title of Class of Securities)

23282W605

 (CUSIP Number)

January 11, 2021

 (Date of Event Which Requires Filing of this
Statement)

 

Check the appropriate box
to designate the rule pursuant to which this Schedule is filed:

 

 

1             
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided
in a prior cover page.

The information required
on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).

 

  1   NAME OF REPORTING PERSON  
         
        Biotechnology Value Fund, L.P.  
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒
        (b) ☐
           
  3   SEC USE ONLY    
           
             
  4   CITIZENSHIP OR PLACE OF ORGANIZATION  
         
        Delaware  
NUMBER OF   5   SOLE VOTING POWER  
SHARES          
BENEFICIALLY         0 shares  
OWNED BY   6   SHARED VOTING POWER  
EACH          
REPORTING         1,439,986  
PERSON WITH   7   SOLE DISPOSITIVE POWER  
         
          0 shares  
    8   SHARED DISPOSITIVE POWER  
           
          1,439,986  
  9  



Read More: Form SC 13G/A CYTOKINETICS INC Filed by: BIOTECHNOLOGY

Leave a reply